Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Since early 2020, the industry for medicinal psychedelic drugs received an extraordinary injection of capital, launching several companies in major exchanges like the NYSE and the Nasdaq, some of which now have valuations of over $1 billion.
Now, in October 2021, the sector has reached a new milestone: 50 companies dedicated to psychedelics in various capacities are listed on U.S. exchanges, giving investors interested in the space a wide array of options to pick from.
Psychedelics Companies Listed On The Nasdaq And NYSE
- Atai Life Sciences (NASDAQ: ATAI)
- Compass Pathways (NASDAQ: CMPS)
- MindMed (NASDAQ: MNMD)
- Field Trip Health, Inc. (NASDAQ: